← back to search

Brandon Leonard

LUNGevity Foundation · US
Area of research
Molecular Biology · Hematology
Research interest
Research interests include Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Monoclonal and Polyclonal Antibodies Research, and Epigenetics and DNA Methylation.
h-index
16
citations
2,295
works
82
NIH funding
primary concept
email

Recent publications

Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members.
PubMed 2020cited by 30position: middledoi
ATR inhibition sensitizes HPV− and HPV+ head and neck squamous cell carcinoma to cisplatin
Oral Oncology 2019cited by 56position: firstdoi
BET Inhibition Overcomes Receptor Tyrosine Kinase–Mediated Cetuximab Resistance in HNSCC
Cancer Research 2018cited by 101position: firstdoi
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer
Science Advances 2016cited by 234position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eliot D. Lee · University of California, San Francisco2 papers (2018–2019)Jennifer R. Grandis · University of California, San Francisco2 papers (2018–2019)Hua Li · University of San Francisco2 papers (2018–2019)Neil E. Bhola · University of California, San Francisco2 papers (2018–2019)Shravan Madireddi · Cancer Research Institute1 papers (2020–2020)Seth F. Harris · Gene Therapy Laboratory1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020)John W.M. Martens · Erasmus MC1 papers (2016–2016)Fred C.G.J. Sweep · Eunice Kennedy Shriver National Institute of Child Health and Human Development1 papers (2016–2016)Christopher J. Bakkenist · UPMC Hillman Cancer Center1 papers (2019–2019) · 1 papers (2016–2016) · 1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020)Rachel I. Vogel · University of New Mexico1 papers (2016–2016)Emily K. Law · University of Minnesota1 papers (2016–2016)Rachel A. O’Keefe · NYU Langone’s Laura and Isaac Perlmutter Cancer Center1 papers (2018–2018)Yan Zeng · University of Science and Technology of China1 papers (2018–2018) · 1 papers (2020–2020)